Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New epilepsy drug study targets seniors

NCT ID NCT07422233

First seen Feb 22, 2026 · Last updated Apr 29, 2026 · Updated 10 times

Summary

This study looked at how well and how safely the drug levetiracetam works for controlling seizures in people aged 60 and older with epilepsy. Researchers tracked how many patients stayed seizure-free, how long they stayed on the drug, and how many stopped due to side effects. The goal was to see if this medication is a good option for elderly patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mazandaran University of medical sciences

    Sari, Mazandaran, 4815733971, Iran

Conditions

Explore the condition pages connected to this study.